Classic Guillain-Barré syndrome (GBS): accounts for approximately 80% of GBS cases
• Also called acute inflammatory demyelinating polyneuropathy (AIDP) because most of the immunemediated injury is directed at the myelin (in severe cases, axons can be affected as well).
• Rapidly progressive, ascending paralysis with distal areflexia and a mild sensory deficit.
• Proximal > distal weakness • History of antecedent viral URI (most commonly due to CMV) or diarrheal illness (due to Campylobacter).
• On CSF exam, classic GBS presents with albuminocytologic dissociation (no WBCs but high protein).
Acute motor axonal neuropathy (AMAN) variant: accounts for approximately 10-15% of GBS cases
• Rapidly progressive, ascending paralysis with normal reflexes (sometimes associated with hyperreflexia) and a no sensory deficit.
• Respiratory failure is common.
• Good prognosis in most patients.
• On pathology there is widespread (and sometimes severe) destruction of axons.
Acute motor sensory axonal neuropathy (AMSAN) variant: rare finding in GBS
• Rapidly progressive, ascending paralysis with areflexia and moderate-to-severe sensory deficits.
• This is a fulminant form of GBS and is associated with widespread axonal injury.
• Prognosis is very poor; recovery is very slow and usually incomplete.
Miller Fischer variant: accounts for approximately 5% of GBS
• Classic triad of ataxia, areflexia, and opthalmoplegia.
• Also can present with mild limb weakness, ptosis, facial palsy and bulbar palsy.
Other variants of GBS:
• Pure sensory • Pure dysautonomic • And many more continue to be described…
Testing and treatment:
• Make the diagnosis by CSF (see above) as well as EMG/NCV and biopsy if necessary • Plasmapheresis is the only proven therapy (Cochrane systematic review) • IVIG may be useful if plasmapheresis is not available • Steroids are not useful.
